Stock 7096 STEMCELL INSTITUTE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials StemCell Institute Inc.

Equities

7096

JP3399640006

Healthcare Facilities & Services

Delayed Japan Exchange
Other stock markets
 10:25:16 2024-05-27 pm EDT 		5-day change 1st Jan Change
1,667 JPY +1.77% Intraday chart for StemCell Institute Inc. -6.87% -22.25%
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. CI
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023. CI

Valuation

Fiscal Period: March 2022 2023 2024 2025 2026
Capitalization 1 20,570 25,770 16,784 - -
Enterprise Value (EV) 1 17,059 22,451 20,288 16,784 16,784
P/E ratio 152 x 130 x 65.2 x 33.6 x 24.7 x
Yield - - - 1.53% 0.61%
Capitalization / Revenue 11.5 x 12.3 x 8.18 x 5.59 x 4.3 x
EV / Revenue 11.5 x 12.3 x 8.18 x 5.59 x 4.3 x
EV / EBITDA 63.7 x 64.1 x 28.9 x 23.6 x 14.9 x
EV / FCF 67,003,407 x -3,221,259,999 x - - -
FCF Yield 0% -0% - - -
Price to Book 9.78 x 11.2 x 7.53 x 5.39 x 5.12 x
Nbr of stocks (in thousands) 10,247 10,247 10,247 - -
Reference price 2 2,008 2,515 1,638 1,638 1,638
Announcement Date 5/12/22 5/11/23 5/14/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net sales 1 1,410 1,781 2,091 2,481 3,000 3,900
EBITDA 1 - 323 401.9 580 710 1,130
EBIT 1 86 226 297 413 600 950
Operating Margin 6.1% 12.69% 14.2% 16.65% 20% 24.36%
Earnings before Tax (EBT) 1 91 212 278 441 759 950
Net income 1 62.37 133 198 310 500 680
Net margin 4.42% 7.47% 9.47% 12.49% 16.67% 17.44%
EPS 2 6.405 13.20 19.33 30.35 48.80 66.40
Free Cash Flow -261 307 -8 - - -
FCF margin -18.52% 17.24% -0.38% - - -
FCF Conversion (EBITDA) - 95.05% - - - -
FCF Conversion (Net income) - 230.83% - - - -
Dividend per Share 2 - - - - 25.00 10.00
Announcement Date 5/21/21 5/12/22 5/11/23 5/14/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Marzo 2021 S1 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 - 865 451 465 916 492 544 1,036 543 512 1,055 577 1,213 671 597 1,268 700 720 780 800
EBITDA - - - - - - - - - - - - - - - - - - - -
EBIT 1 - 110 58 58 116 73 90 163 98 36 134 88 215 141 57 198 130 130 170 170
Operating Margin - 12.72% 12.86% 12.47% 12.66% 14.84% 16.54% 15.73% 18.05% 7.03% 12.7% 15.25% 17.72% 21.01% 9.55% 15.62% 18.57% 18.06% 21.79% 21.25%
Earnings before Tax (EBT) 1 - 95 58 59 117 74 90 164 99 15 114 114 240 142 59 201 - - - -
Net income 1 - 60 37 36 73 50 60 110 62 26 88 75 159 95 56 151 110 120 120 150
Net margin - 6.94% 8.2% 7.74% 7.97% 10.16% 11.03% 10.62% 11.42% 5.08% 8.34% 13% 13.11% 14.16% 9.38% 11.91% 15.71% 16.67% 15.38% 18.75%
EPS - 6.090 3.580 - - 4.940 - 10.75 12.12 - - 7.390 15.59 9.290 - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date - 11/9/21 2/8/22 5/12/22 5/12/22 8/4/22 11/8/22 11/8/22 2/7/23 5/11/23 5/11/23 8/8/23 11/8/23 2/7/24 5/14/24 5/14/24 - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position 2,743 3,511 3,319 - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow -261 307 -8 - - -
ROE (net income / shareholders' equity) 4.8% 7.8% 9% 12.5% 17.2% 21.3%
ROA (Net income/ Total Assets) - 4.62% 5.44% 6.75% 8.4% 11.3%
Assets 1 - 2,877 3,639 4,592 5,952 6,018
Book Value Per Share 2 136.0 205.0 224.0 263.0 304.0 320.0
Cash Flow per Share 9.660 22.60 29.50 42.00 - -
Capex 1 499 162 107 100 150 800
Capex / Sales 35.4% 9.1% 5.12% 3.89% 5% 20.51%
Announcement Date 5/21/21 5/12/22 5/11/23 5/14/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for StemCell Institute Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
STEMCELL INSTITUTE INC. Stock StemCell Institute Inc.
-22.25% 109M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.74% 83.47B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.66% 69.72B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-0.49% 26.22B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.03% 17.69B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-12.16% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.47% 15.7B
NATERA, INC. Stock Natera, Inc.
+74.82% 13.45B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.52% 12.81B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-0.76% 12.69B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 7096 Stock
  4. Financials StemCell Institute Inc.